Search research articles
Contact Us
Filters
Showing results (241-250 of 255) with videos related to
Page
of 26
Sort By:
Human Molecular Genetics
|
November 1, 1996
Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews
A Nestorowicz, B A Wilson, K P Schoor, et al.
Cell
|
November 13, 2012
Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses
James P Clement, Massimiliano Aceti, Thomas K Creson, et al.
Ebiomedicine
|
November 16, 2019
Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration
Suresh Sn, Janhavi Pandurangi, Ravi Murumalla, et al.
The New England Journal of Medicine
|
March 6, 1997
Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor
M J Dunne, C Kane, R M Shepherd, et al.
European Journal of Clinical Pharmacology
|
January 4, 2007
The effect of MK-0524, a prostaglandin D(2) receptor antagonist, on prostaglandin D (2)-induced nasal airway obstruction in healthy volunteers
A Van Hecken, M Depré, I De Lepeleire, et al.
Prenatal Diagnosis
|
March 16, 2011
Prenatal BACs-on-Beads™ : a new technology for rapid detection of aneuploidies and microdeletions in prenatal diagnosis
F Vialard, G Simoni, A Aboura, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort
S Thijssen, H Wildiers, K Punie, et al.
Sarcoma
|
April 18, 2020
Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis
P Schöffski, I Timmermans, D Hompes, et al.
Sarcoma
|
February 25, 2021
Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis"
P Schöffski, I Timmermans, D Hompes, et al.
British Journal of Cancer
|
November 12, 2009
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
D A Reardon, G Dresemann, S Taillibert, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 255) with videos related to
Sort By:
Page
of 26
Human Molecular Genetics
|
November 1, 1996
Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews
A Nestorowicz, B A Wilson, K P Schoor, et al.
Cell
|
November 13, 2012
Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses
James P Clement, Massimiliano Aceti, Thomas K Creson, et al.
Ebiomedicine
|
November 16, 2019
Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration
Suresh Sn, Janhavi Pandurangi, Ravi Murumalla, et al.
The New England Journal of Medicine
|
March 6, 1997
Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor
M J Dunne, C Kane, R M Shepherd, et al.
European Journal of Clinical Pharmacology
|
January 4, 2007
The effect of MK-0524, a prostaglandin D(2) receptor antagonist, on prostaglandin D (2)-induced nasal airway obstruction in healthy volunteers
A Van Hecken, M Depré, I De Lepeleire, et al.
Prenatal Diagnosis
|
March 16, 2011
Prenatal BACs-on-Beads™ : a new technology for rapid detection of aneuploidies and microdeletions in prenatal diagnosis
F Vialard, G Simoni, A Aboura, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort
S Thijssen, H Wildiers, K Punie, et al.
Sarcoma
|
April 18, 2020
Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis
P Schöffski, I Timmermans, D Hompes, et al.
Sarcoma
|
February 25, 2021
Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis"
P Schöffski, I Timmermans, D Hompes, et al.
British Journal of Cancer
|
November 12, 2009
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
D A Reardon, G Dresemann, S Taillibert, et al.
Page
of 26